KIAA1704, a designation often used in the context of human genetics and proteomics, refers to a protein encoded by a gene identified in large-scale sequencing projects, particularly those originating from the Kazusa DNA Research Institute in Japan. The acronym "KIAA" stands for Kazusa Institute cDNA sequencing project, and the numbers that follow correspond to the specific cDNA clone in their library. Proteins like KIAA1704 are usually characterized by having relatively little information available about their function, structure, or role in the cell when first identified.
The KIAA1704 protein, like many proteins initially identified through these sequencing efforts, is typically subjected to further bioinformatics analysis and experimental studies to elucidate its biological significance. This includes investigating its expression patterns, cellular localization, post-translational modifications, and potential interactions with other proteins. Additionally, researchers may explore the evolutionary conservation of the protein to predict its importance and potential functions.Due to the preliminary nature of the information available for KIAA1704, its functions and interactions are not well-defined, making it a subject of ongoing scientific inquiry. Scientists may use a variety of techniques, such as gene knockdown or overexpression studies, to determine the phenotypic consequences of altering KIAA1704 levels in cells or organisms. Moreover, protein-protein interaction assays could reveal the molecular pathways KIAA1704 may be involved in.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, potentially altering gene expression patterns that could affect FAM208A. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, can impact chromatin remodeling and gene expression, potentially influencing FAM208A. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Influences histone acetylation, potentially affecting gene expression including FAM208A. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Acts as a histone deacetylase inhibitor, which might influence gene expression relevant to FAM208A. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various cellular pathways, potentially impacting FAM208A through epigenetic changes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, could affect cellular processes related to FAM208A's function. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling, which could intersect with pathways involving FAM208A. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Affects gene expression, potentially influencing pathways related to FAM208A. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, might impact chromatin structure and gene expression relevant to FAM208A. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Autophagy inhibitor, potentially affecting cellular pathways linked to FAM208A. | ||||||